Prestige Estates Projects Ltd. - Research Center
533274 PRESTIGE Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 1,575.40 | 1,494.70 | 1,765.80 | 2,850.00 | 1,709.20 |
| Operating profit | 360.70 | 428.30 | 418.90 | 560.40 | 267.80 |
| Interest | 281.10 | 193.90 | 153.70 | 151.60 | 143.60 |
| Gross profit | 230.20 | 368.20 | 324.90 | 553.40 | 291.20 |
| EPS (Rs) | 0.87 | 4.19 | 3.93 | 20.53 | 3.10 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 150.60 | 133.80 | 59.70 | 144.60 | 167.00 |
| Stock adjustment | -408.70 | 66.80 | -401.40 | 1,270.80 | 424.40 |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 200.40 | 150.60 | 130.10 | 115.10 | 113.60 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,423.00 | 849.00 | 1,618.20 | 903.70 | 903.40 |
| Provisions made | - | - | - | - | - |
| Depreciation | 211.80 | 188.40 | 154.70 | 144.50 | 140.10 |
| Taxation | -19.20 | 11.80 | 33.10 | 125.80 | 26.70 |
| Net profit / loss | 37.60 | 168.00 | 157.50 | 823.00 | 124.40 |
| Extra ordinary item | - | - | 20.40 | 539.90 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 430.70 | 400.90 | 400.90 | 400.90 | 400.90 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 22.90 | 28.65 | 23.72 | 19.66 | 15.67 |
| GPM (%) | 13.34 | 22.61 | 17.80 | 18.48 | 15.52 |
| NPM (%) | 2.18 | 10.32 | 8.63 | 27.48 | 6.63 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis